VTRLY Stock - Vitrolife AB (publ)
Unlock GoAI Insights for VTRLY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.61B | $3.51B | $3.23B | $1.68B | $1.25B |
| Gross Profit | $2.14B | $1.98B | $1.78B | $1.05B | $767.67M |
| Gross Margin | 59.3% | 56.3% | 55.0% | 62.2% | 61.6% |
| Operating Income | $783.00M | $-3,589,000,000 | $654.00M | $435.38M | $370.01M |
| Net Income | $513.00M | $-3,851,000,000 | $394.00M | $341.00M | $286.85M |
| Net Margin | 14.2% | -109.7% | 12.2% | 20.3% | 23.0% |
| EPS | $3.79 | $-28.44 | $2.91 | $2.97 | $2.64 |
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
Visit WebsiteEarnings History & Surprises
VTRLYEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 22, 2026 | — | — | — | — |
Q1 2026 | Jan 29, 2026 | — | — | — | — |
Q4 2025 | Oct 23, 2025 | — | $0.01 | — | — |
Q3 2025 | Jul 17, 2025 | — | $0.08 | — | — |
Q2 2025 | Apr 24, 2025 | — | $0.07 | — | — |
Q1 2025 | Jan 30, 2025 | — | $0.09 | — | — |
Q4 2024 | Oct 24, 2024 | — | $0.08 | — | — |
Q3 2024 | Jul 17, 2024 | — | $0.10 | — | — |
Q2 2024 | Apr 18, 2024 | — | $0.08 | — | — |
Q1 2024 | Feb 2, 2024 | — | $-3.05 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.08 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.07 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.07 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.05 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.07 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.09 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.06 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.03 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.10 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.09 | — | — |
Latest News
Frequently Asked Questions about VTRLY
What is VTRLY's current stock price?
What is the analyst price target for VTRLY?
What sector is Vitrolife AB (publ) in?
What is VTRLY's market cap?
Does VTRLY pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to VTRLY for comparison